Phase 1 GLP-1/FGF21 agonist This compound is under investigation, further information will be available soon. Anchored in external partnership or acquisition Partnering inquiries Join our team Additional links Innovation in Cardio-Renal-Metabolic Diseases Metabolic Diseases Partnering in Cardiometabolic Diseases
